CHANG DAVID D (President and CEO) sold 0.9% of their position (47.76K shares) of ALLOGENE THERAPEUTICS, INC. on the open market
Open‑market sale worth $118.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001737287-26-000013
DirectorOfficer· President and CEO
Since Oct 2018
-47.76K
Net shares
Net seller
$118.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
47.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−47.76K
Price / share
$2.47
Trade value
$117.97K
% of position
0.9%
3/16/2026
5.20M→5.15M
Total
Net shares
−47.76K
Net value
-$117.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −47.76K | $2.47 | $117.97K | 0.9% | 5.20M | 5.15M |
| Total | −47.76K | -$117.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned856.04K
Common Stock
IndirectShares owned856.04K
Total
2.91M indirect2.91M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.20M | Indirect |
| Common Stock | 856.04K | Indirect |
| Common Stock | 856.04K | Indirect |
| Total | 2.91M | 2.91M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported